Statement Of Cash Flows [Abstract]

ROQUEFORT THERAPEUTICS PLC - Filing #5968009

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
783,731 GBP
1,733,533 GBP
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
GBP
54,042 GBP
Interest received, classified as investing activities
GBP
1,469 GBP
Cash flows from (used in) investing activities
GBP
52,573 GBP
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
584,915 GBP
GBP
Interest paid, classified as financing activities
GBP
58 GBP
Cash flows from (used in) financing activities
584,915 GBP
58 GBP
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
198,816 GBP
1,786,164 GBP
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1,394 GBP
512 GBP
Cash and cash equivalents
337,112 GBP
537,322 GBP
2,322,974 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.